Alison Kodjak
-
An interdisciplinary team in San Francisco uses acupressure, massage, counseling and other methods, as well as medicine, to help kids get relief from chronic pain. But such pediatric centers are rare. -
A former official in the civil rights office says the unit seems afraid to offend U.S. Customs and Border Protection and ICE. Meanwhile, the complaints of abuses of families continue to pile up. -
Certain high-cost drugs are straining state budgets. A new deal approved Wednesday allows Louisiana to spend a fixed amount for unlimited access to a costly cure. Other states may try to follow suit. -
A quirk in the law gives an older opioid addiction treatment "orphan drug" status — and a period of exclusive market access. That may prevent some new therapies from reaching patients for years. -
The rule strengthens protections for health care providers who are unwilling to provide services like abortions. Critics say it could put women's health in danger. -
The Senate Finance Committee will hear Tuesday from executives from the biggest pharmacy benefit managers. Confidential rebates paid to the PBMs are expected to draw scrutiny. -
Lawmakers in the House and Senate are pressing companies to lower prices for insulin which is essential for many people with diabetes. The price is 10 times higher today than it was 20 years ago.
-
The Trump administration wants to increase transparency in prescription drug pricing. But health economists say the administration's call to tie prices to what other nations pay might work better. -
A little-noticed Trump administration proposal would require hospitals, doctors and insurers to post the true, negotiated price for a medical procedure or service, as opposed to the "list" price. -
With almost 10,000 stores across the country, CVS says it is already where consumers are. The company is transforming some of its stores and their retail clinics into hubs for a wider range of care.
